Looking to engage with our member community by contributing to ASAP’s content? Send your blog post, article draft, or idea to Michael Burke at mburke@strategic-alliances.org
With the impending retirement later this month of ASAP president and CEO Michael Leonetti, CSAP, “a key feature of our alliance community” is moving on, ushering in a new era for ASAP. That was the description given by Brooke Paige, CSAP, digital alliance leader at Novartis, as she... Continue Reading
Change is a constant in biopharma partnering, and a panel of alliance leaders examined the skills and capabilities needed to confront the ongoing challenges on opening day of the 2023 ASAP BioPharma Conference in Boston. Continue Reading
Day 2 of the 2023 ASAP BioPharma Conference kicked off with a panel exploring the world of drug development technology platform alliances—multiple programs, therapeutic areas, and indications. IP protection, stakeholder management, and surprises, big and small, put alliance managers to the test. Continue Reading
Empathy helps helps drive powerful outcomes for patients and consumers—and great business outcomes! So said Doug Wenners during his ASAP BioPharma Conference keynote presentation. Continue Reading
Day One of the 2023 ASAP BioPharma Conference is here! And the Leadership Forum looked at the emerging role of the alliance operations manager along with all that goes into the making of a true collaborative competency. Continue Reading
ASAP has appointed Nicole Boston new CEO, and she brings a track record of tremendous success and growth in heading professional associations. Continue Reading
Novel but risky research projects. A portfolio approach to joint initiatives. Increased collaboration earlier in the research phase. Julie Little expanded on Cancer Research Technology's recipe for success from the nonprofit's perspective of the biopharma ecosystem at ASAP's annual European event. Continue Reading
The 2023 ASAP BioPharma Conference is coming to Boston next week, and among the many highlights will be a veritable parade of panel discussions. The leading lights and illustrious luminaries of alliances will help you navigate a constantly changing landscape of biopharma partnering. Continue Reading
Empathy and the patient journey have always been primary drivers for alliance managers in the biopharma industry. Doug Wenners will show ASAP BioPharma Conference attendees how to take their commitment one step further. Continue Reading
How should they integrate risk management into their month-to-month duties? What can they do to not only keep tabs on the biggest risk factors facing their collaborations, but also maintain engagement from primary relevant stakeholders? And what does software have to do with it? Continue Reading
How do you instill a collaborative culture within an ecosystem? Model collaborative behaviors rather than relying solely on mission statements and charters—people will do as you do, not as you say—and be flexible! Continue Reading
Are you doing the right things that will propel your alliance to success? Or just going through the motions? One of the highlight sessions from last month's ASAP European Alliance Summit suggests that the data on what kinds of activities make for a high-performing alliance is abundantly clear. Continue Reading
